SOURCE: SkyePharma PLC

September 19, 2007 11:53 ET

SkyePharma PLC - UBS Life Sciences Conference

London, UK--(Marketwire - September 19, 2007) -

                   SKYEPHARMA TO PRESENT AT UBS 2007

LONDON, UK, 19 September 2007-- SkyePharma PLC (LSE: SKP) announces today that the Company's Chief Executive Officer, Frank Condella, will make a presentation at the UBS 2007 Global Life Sciences Conference in New York. Mr Condella will deliver his presentation on Thursday 27 September 2007 at 12.30 p.m. EDT (5.30 p.m. UKT). Investors may access an audio webcast of the presentation at under the Investor Relations tab.

For further information please contact:

SkyePharma PLC                      Frank Condella     +44 20 7491 1777
                                    Ken Cunningham
                                    Peter Grant

Financial Dynamics (UK Enquiries)   David Yates         +44 20 7831 3113
                                    Deborah Scott

Trout Group (US Enquiries)          Christine Labaree   +1 617 583 1308
                                    Seth Lewis

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has eleven approved products in the areas of oral, inhalation and topical delivery that are marketed throughout the world by leading pharmaceutical companies.

For more information, visit

                   This information is provided by RNS
         The company news service from the London Stock Exchange